EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

MS Aapro; DA Cameron; R Pettengell; J Bohlius; J Crawford; M Ellis; N Kearney; GH Lyman; VC Tjan-Heijnen; J Walewski; DC Weber; C Zielinski

doi:10.1016/j.ejca.2006.05.002

Back

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

Journal article

Peer reviewed

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

MS Aapro, DA Cameron, R Pettengell, J Bohlius, J Crawford, M Ellis, N Kearney, GH Lyman, VC Tjan-Heijnen, J Walewski, …

EUROPEAN JOURNAL OF CANCER, Vol.42(15), pp.2433-2453

01/10/2006

DOI: https://doi.org/10.1016/j.ejca.2006.05.002

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

ONCOLOGY

antineomastic agents

filgrastim

granulocyte colony-stimulating factor

lenograstim

neoplasms

neutropenia

pegfilgrastim

guideline

CELL LUNG-CANCER

PHASE-III TRIAL

NON-HODGKINS-LYMPHOMA

METASTATIC BREAST-CANCER

MULTICENTER RANDOMIZED-TRIAL

PACLITAXEL PLUS CARBOPLATIN

COOPERATIVE ONCOLOGY GROUP

EPITHELIAL OVARIAN-CANCER

SINGLE-ADMINISTRATION PEGFILGRASTIM

3-WEEKLY CHOP CHEMOTHERAPY

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241926300013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

56 Record Views

391 Times Cited - Web of Science

See more details

Details

Title: EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
Creators: MS Aapro
DA Cameron
R Pettengell
J Bohlius
J Crawford
M Ellis
N Kearney
GH Lyman
VC Tjan-Heijnen
J Walewski
DC Weber
C Zielinski
Publication Details: EUROPEAN JOURNAL OF CANCER, Vol.42(15), pp.2433-2453
Publisher: ELSEVIER SCI LTD
Date published: 01/10/2006
Date submitted: 17/05/2017
Identifiers: 99514265102346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

Abstract

Files and links (1)

Metrics

Details

Usage Policy